Obstetrics and Gynecology

1046 soru

Soru 901Soru →

A 66-year-old G3P3 woman is evaluated on postoperative day 2 following a vaginal uterosacral ligament hysteropexy and anterior colporrhaphy for symptomatic stage III pelvic organ prolapse. She reports right-sided back pain, nausea, and mild vaginal spotting. The Foley catheter was removed yesterday, and she has been voiding spontaneously in adequate volumes.

Physical examination reveals marked right costovertebral angle tenderness. The vaginal vault is intact with minimal serosanguinous discharge.

Vital SignsValue
Temperature38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F})
Blood pressure140/85 mm Hg140/85\text{ mm Hg}
Heart rate102/min102/\text{min}
Laboratory StudiesValue
Leukocyte count12,000/mm312,000/\text{mm}^3
Serum creatinine1.1 mg/dL1.1\text{ mg/dL} (Baseline: 0.8 mg/dL0.8\text{ mg/dL})
Urinalysis
Leukocyte esteraseNegative
NitritesNegative
WBCs1-2/hpf
RBCs3-5/hpf
BacteriaNone

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Renal ultrasonography

Cevap

Renal ultrasonography
This patient is presenting with signs of a unilateral ureteral obstruction (right-sided flank pain, costovertebral angle tenderness, a mild rise in creatinine, and fever) on postoperative day 2 following a vaginal uterosacral ligament hysteropexy. The uterosacral ligaments lie in close anatomic proximity to the ureters, making ureteral kinking, compression, or ligation a known complication of this procedure (occurring in up to 5% of cases). Unilateral obstruction may not cause oliguria or anuria if the contralateral kidney is functioning properly, but it rapidly leads to acute hydronephrosis and stretching of the renal capsule, causing severe flank pain. Tissue inflammation can lead to a low-grade fever and mild leukocytosis. Crucially, the urinalysis is negative for infectious signs, ruling out acute pyelonephritis, though surgical trauma often causes microscopic hematuria. The most appropriate next step is noninvasive imaging with renal ultrasonography to evaluate for hydroureter and hydronephrosis.

Adım Adım Çözüm

1
Analyze the patient's postoperative timeline and symptoms.
The patient presents with fever, right-sided flank pain, nausea, and a mild serum creatinine elevation on postoperative day 2 following a uterosacral ligament hysteropexy.
Establishing the timing and localized nature of symptoms helps narrow down the differential diagnosis of postoperative complications.
2
Evaluate the laboratory findings, specifically the urinalysis.
The urinalysis shows no signs of infection (negative leukocyte esterase, nitrites, and bacteria) but reveals trace hematuria.
A benign urinalysis effectively rules out acute pyelonephritis as the cause of her fever and costovertebral angle tenderness, pointing instead to a non-infectious, mechanical renal etiology.
3
Correlate the clinical picture with the specific anatomical risks of the surgical procedure.
Uterosacral ligament suspension carries a 1% to 5% risk of ureteral kinking or ligation due to the anatomic proximity of the ureter to the ligament.
Recognizing procedure-specific risks is essential; unilateral ureteral obstruction explains the acute hydronephrosis (causing flank pain and fever) and the mild acute kidney injury.
4
Determine the most appropriate initial diagnostic modality.
Renal ultrasonography is selected as the next step.
It is a fast, noninvasive, and highly sensitive bedside imaging test for detecting hydroureter and hydronephrosis resulting from suspected ureteral obstruction.

Anahtar Kavram

Ureteral obstruction is a recognized complication of uterosacral ligament suspension. It typically presents acutely with flank pain, fever, and a normal or slightly hematuric urinalysis; the initial diagnostic step is noninvasive imaging with renal ultrasonography.
Tahmini Süre:1m 30s
Soru 902Soru →

A 71-year-old multiparous woman is evaluated in the urogynecology clinic for a persistent vaginal bulge and pelvic pressure that has progressively worsened over the past year. She also reports a single episode of scant, bright red vaginal spotting three weeks ago, which she attributed to the bulge rubbing against her clothing. She went through menopause at age 52 and has not seen a physician in over a decade. Her medical history includes well-controlled hypertension. On physical examination, there is stage III pelvic organ prolapse with the cervix protruding past the hymenal ring. A 1.5-cm superficial, non-bleeding erosion is noted on the dependent portion of the prolapsed cervix. A transvaginal ultrasound reveals a homogeneous endometrial stripe of 8 mm and normal-appearing adnexa. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Endometrial biopsy

Cevap

Endometrial biopsy
The correct answer is endometrial biopsy. This patient presents with postmenopausal bleeding (PMB) and a transvaginal ultrasound showing an endometrial stripe of 8 mm. In a postmenopausal woman, the endometrium should be thin and atrophic. Current clinical guidelines mandate that an endometrial thickness strictly greater than 4 mm in the setting of PMB requires tissue sampling to evaluate for endometrial hyperplasia or carcinoma. Although the patient has a stage III pelvic organ prolapse with a visible cervical erosion (a decubitus ulcer)—which is a highly plausible mechanical source for her spotting—the presence of an abnormal endometrial stripe means endometrial malignancy must be definitively ruled out before pursuing therapies for the prolapse.

Adım Adım Çözüm

1
Identify the primary concerning clinical finding in the vignette.
The patient has an episode of postmenopausal bleeding and an ultrasound demonstrating an 8-mm endometrial stripe.
An endometrial thickness greater than 4 mm in a postmenopausal woman with bleeding is highly suspicious for endometrial hyperplasia or carcinoma.
2
Evaluate the competing benign etiology.
The patient has severe pelvic organ prolapse with a decubitus ulcer (cervical erosion), which can also cause spotting.
Students must not succumb to anchoring bias; while the ulcer is a plausible source of bleeding, it does not explain the thickened endometrium.
3
Determine the mandatory next step based on guidelines.
Endometrial biopsy is selected.
Regardless of concurrent benign findings, any postmenopausal woman with bleeding and an endometrial stripe > 4 mm must undergo tissue sampling before initiating any treatments or definitive surgeries.

Anahtar Kavram

Postmenopausal bleeding accompanied by an endometrial thickness > 4 mm mandates immediate endometrial biopsy, even when a competing benign source of bleeding (such as a prolapse-associated decubitus ulcer) is identified.
Soru 903Soru →

An otherwise healthy 39-year-old woman presents to the reproductive endocrinology clinic to discuss her difficulty becoming pregnant. For the last 10 months, she and her male partner have engaged in regular, unprotected coitus targeting her fertile window. Her menstrual cycles occur regularly every 24 to 25 days, with menses lasting 4 days. She notes that in her early twenties, her cycles were consistently 28 days long. She reports mild, intermittent facial acne that she has had since her teenage years, as well as occasional night sweats occurring a few days prior to the onset of her period. Medical and surgical history are unremarkable. She takes a daily prenatal vitamin. Vital signs are within normal limits, and her body mass index is 22 kg/m222 \text{ kg/m}^2. Bimanual pelvic examination reveals a normal-sized, mobile uterus with no adnexal masses. Her partner's semen analysis shows normal volume, concentration, and motility. Initial laboratory testing on the third day of her menstrual cycle reveals the following:

Laboratory ParameterPatient ValueReference Range
Follicle-stimulating hormone18 mIU/mL18 \text{ mIU/mL}3−10 mIU/mL3-10 \text{ mIU/mL}
Luteinizing hormone7 mIU/mL7 \text{ mIU/mL}2−10 mIU/mL2-10 \text{ mIU/mL}
Estradiol55 pg/mL55 \text{ pg/mL}25−75 pg/mL25-75 \text{ pg/mL}
Thyroid-stimulating hormone1.8 \muU/mL1.8 \text{ \mu U/mL}0.5−4.0 \muU/mL0.5-4.0 \text{ \mu U/mL}
Prolactin14 ng/mL14 \text{ ng/mL}<25 ng/mL< 25 \text{ ng/mL}

Which of the following is the most likely primary underlying mechanism for this patient's difficulty conceiving?

Cevabı ve açıklamayı göster

Cevap: Decreased residual pool of primordial follicles

Cevap

Decreased residual pool of primordial follicles
The correct underlying mechanism is a decreased residual pool of primordial follicles, which defines Diminished Ovarian Reserve (DOR). In women of late reproductive age (typically >35 years), the natural age-related decline in oocyte quantity and quality leads to decreased production of inhibin B by the ovarian granulosa cells. The loss of this negative feedback loop causes the anterior pituitary to secrete more follicle-stimulating hormone (FSH) during the early follicular phase. This elevated FSH accelerates the recruitment and maturation of the dominant follicle, resulting in early ovulation and a shortened follicular phase. Clinically, this manifests as a progressively shorter overall menstrual cycle (e.g., a shift from 28 days to 24 days), while maintaining regular menses. The patient's age, shortening cycles, mild vasomotor symptoms due to fluctuating estrogen, and explicitly elevated day 3 FSH are classic hallmarks of DOR.

Adım Adım Çözüm

1
Analyze the patient's age and menstrual history.
The patient is a 39-year-old with regular, but shortening menstrual cycles (shifted from 28 days to 24-25 days) and occasional premenstrual vasomotor symptoms (night sweats).
Identifying changes in cycle length in women in their late 30s is critical for distinguishing normal reproductive aging from pathological amenorrhea.
2
Interpret the Day 3 laboratory values.
FSH is elevated at 18 mIU/mL. LH, estradiol, TSH, and prolactin are all within normal limits.
An isolated early follicular phase FSH elevation indicates an altered hypothalamic-pituitary-ovarian feedback loop, specifically a lack of negative feedback.
3
Synthesize findings to determine the underlying mechanism.
The combination of advanced reproductive age, regular but shorter cycles, and elevated day 3 FSH points to Diminished Ovarian Reserve (DOR) driven by a reduced pool of primordial follicles.
DOR must be differentiated from Primary Ovarian Insufficiency (POI), which would present with frank amenorrhea and much higher FSH levels, and from PCOS, which would present with irregular menses and normal FSH.

Anahtar Kavram

Diminished Ovarian Reserve (DOR) presents in women of late reproductive age with regular but shortening menstrual cycles and elevated day 3 FSH due to a decreased pool of primordial follicles and subsequent drop in inhibin B.
Tahmini Süre:1m 30s
Soru 904Soru →

A 61-year-old woman is evaluated for a 1-year history of sudden, overwhelming urges to urinate accompanied by frequent, large-volume urinary leakage. She has no neurologic deficits, and a recent urinalysis was unremarkable. Post-void residual volume is 25 mL. Evaluation confirms non-neurogenic urgency urinary incontinence. According to standard clinical guidelines, arrange the following therapeutic interventions in the correct escalating sequence, starting from the initial first-line approach to the treatment of last resort for severely refractory symptoms.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence escalates from behavioral modifications, to oral pharmacotherapy, then to minimally invasive advanced procedures, and finally to major reconstructive surgery.
The management of urgency urinary incontinence follows a strict, escalating pathway designed to balance efficacy with the risk of adverse events. First-line therapy consists of non-invasive behavioral modifications (fluid management, bladder training, and pelvic floor muscle exercises). If symptoms persist, second-line therapy with oral medications (antimuscarinics or beta-3 agonists) is initiated. For patients who are refractory to or cannot tolerate oral medications, third-line advanced therapies (intravesical botulinum toxin A, sacral neuromodulation, or PTNS) are recommended. Finally, major reconstructive surgery (augmentation enterocystoplasty) is the definitive treatment of last resort for severely refractory cases.

Adım Adım Çözüm

1
Identify the primary diagnosis and underlying pathophysiology.
The clinical presentation of sudden, overwhelming urges to urinate with large-volume leakage, normal urinalysis, and low post-void residual indicates non-neurogenic urgency urinary incontinence (overactive bladder).
Establishing the correct diagnosis dictates the specific treatment algorithm to follow.
2
Determine the recommended first-line therapy.
Behavioral modifications, including scheduled voiding, fluid management, and pelvic floor muscle training, are the initial step.
These interventions are highly effective, carry no risk of medication side effects, and are the least invasive.
3
Identify the appropriate second-line therapy for persistent symptoms.
Oral pharmacotherapy with antimuscarinics or beta-3 adrenergic agonists.
Medications are introduced when behavioral interventions alone fail to provide adequate symptom control.
4
Determine the third-line options for medication-refractory cases.
Minimally invasive procedures such as intravesical onabotulinumtoxinA injections, sacral neuromodulation, or PTNS.
These are utilized when patients fail or cannot tolerate the side effects of oral medications.
5
Identify the treatment of absolute last resort.
Major surgical interventions like augmentation enterocystoplasty or urinary diversion.
These carry significant morbidity and are only considered in exceptionally severe, refractory cases.

Anahtar Kavram

The standard stepwise management of non-neurogenic urgency urinary incontinence (overactive bladder) escalates from behavioral therapies (first-line) to oral medications (second-line), then to advanced minimally invasive procedures (third-line), and rarely to major reconstructive surgery (last resort).
Soru 905Soru →

A 26-year-old woman is undergoing a suction dilation and curettage for a missed abortion. During the procedure, the physician notes a sudden loss of resistance while advancing the suction curette. Upon withdrawing the instrument, yellow, fatty tissue is seen within the cannula. The patient is under monitored anesthesia care. Her blood pressure is 105/65 mm Hg and heart rate is 102/min.

Arrange the following management steps in the most appropriate chronological sequence for this patient's acute complication.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: immediately halt the procedure, assess hemodynamic stability, perform a diagnostic laparoscopy/laparotomy, and then surgically repair any identified defects.
When a uterine perforation is suspected during a dilation and curettage, the most critical initial step is to stop the procedure immediately to prevent further damage. The presence of fatty tissue indicates that the curette has entered the peritoneal cavity and grasped omentum. This mandates an immediate assessment of the patient's hemodynamic status to prepare for surgery. Because abdominal contents have been drawn into the uterus, a diagnostic laparoscopy or laparotomy is required to thoroughly inspect the bowel and other viscera. Finally, definitive surgical repair of the uterus and any injured adjacent structures is performed.

Adım Adım Çözüm

1
Recognize the perforation and immediately halt the procedure.
Prevents further intra-abdominal organ injury.
Loss of resistance and retrieval of fatty tissue (omentum) confirms a full-thickness uterine perforation. Continuing suction would cause severe bowel or vascular injury.
2
Assess the patient's hemodynamic stability and ensure intravenous access.
Prepares the patient for emergency surgery and potential fluid resuscitation.
Uterine perforation can injure major pelvic vessels, leading to rapid intra-abdominal hemorrhage.
3
Perform a diagnostic laparoscopy or laparotomy.
Visualizes the extent of the intra-abdominal damage.
Because omentum was pulled through the defect, there is a high likelihood of concurrent bowel or visceral injury that must be identified via direct visualization.
4
Surgically repair the uterine defect and associated injuries.
Definitively treats the complication.
Once the full extent of the injury is mapped, surgical repair of the uterus and any damaged bowel or vessels is performed.

Anahtar Kavram

Management sequence for complicated uterine perforation with suspected visceral injury.
Soru 906Soru →

A 23-year-old nulliparous woman comes to the clinic because she found a lump in her right breast 2 weeks ago. She has no family history of breast cancer or other malignancies. Menarche was at age 12, and her menses are regular, occurring every 28 days. She takes no medications. On physical examination, her temperature is 37.0°C (98.6°F), blood pressure is 110/70 mm Hg, and pulse is 72/min. Breast examination reveals a 2-cm, firm, mobile, rubbery, well-circumscribed, non-tender mass in the upper outer quadrant of the right breast. There is no overlying skin erythema, dimpling, nipple retraction, or abnormal discharge. Examination of the axillae reveals no palpable lymphadenopathy. Which of the following is the most appropriate next step in evaluation?

Cevabı ve açıklamayı göster

Cevap: Targeted ultrasound of the breast

Cevap

Targeted ultrasound of the breast
The correct answer is targeted ultrasound of the breast. When a patient presents with a palpable breast mass, the initial workup depends primarily on the patient's age. For women under the age of 30, targeted breast ultrasound is the first-line imaging modality. This is because young women typically have radiographically dense breast tissue, which makes mammography difficult to interpret and less sensitive for detecting abnormalities. Ultrasound can accurately characterize the mass as simple cystic, complex cystic, or solid. If the mass is solid, the ultrasound features can help determine whether it appears benign (e.g., fibroadenoma, which this patient likely has) or suspicious, thereby guiding the decision for subsequent tissue biopsy.

Adım Adım Çözüm

1
Identify the patient's age and clinical presentation.
The patient is a 23-year-old woman presenting with a new, discrete, palpable breast mass that feels clinically benign (firm, mobile, rubbery).
Age and clinical findings determine the diagnostic algorithm for breast masses.
2
Determine the appropriate initial diagnostic modality based on the patient's age.
For women under age 30, ultrasound is the first-line modality.
Young women typically have dense breast tissue, which decreases the sensitivity of mammography. Ultrasound effectively characterizes the mass (solid vs. cystic) and can guide biopsy if necessary.

Anahtar Kavram

In women under 30 years of age presenting with a palpable breast mass, targeted ultrasound is the most appropriate initial imaging step. For women 30 years of age and older, diagnostic mammography is preferred.
Soru 907Soru →

A 31-year-old woman comes to the reproductive endocrinology clinic due to an inability to conceive for the past 14 months. Her menstrual periods were regular until two years ago, when they became irregular, and she has had no menses for the past 8 months. During this time, she has gained 8 kg (17.6 lb) and reports progressive fatigue, cold intolerance, and constipation. She also reports occasional clear, milky discharge from both nipples. Her BMI is 28.5 kg/m². Vital signs show a pulse of 54/min and a blood pressure of 105/65 mmHg. Physical examination reveals delayed relaxation of the deep tendon reflexes and bilateral galactorrhea. Pelvic examination is normal. A urine pregnancy test is negative.

Laboratory evaluation shows:
Follicle-stimulating hormone: 2.2 mIU/mL
Luteinizing hormone: 1.8 mIU/mL
Prolactin: 78 ng/mL (normal: 4-23 ng/mL)
Thyroid-stimulating hormone (TSH): 0.2 mU/L (normal: 0.5-5.0 mU/L)
Free thyroxine (T4): 0.4 ng/dL (normal: 0.9-1.7 ng/dL)

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Magnetic resonance imaging of the brain

Cevap

Magnetic resonance imaging of the brain
The correct answer is magnetic resonance imaging (MRI) of the brain. This patient presents with secondary amenorrhea, galactorrhea, and symptoms of severe hypothyroidism. Her laboratory evaluation reveals a low free T4 with an inappropriately low TSH, which is diagnostic of central (secondary) hypothyroidism. In contrast, primary hypothyroidism would present with an elevated TSH. She also has mild hyperprolactinemia (78 ng/mL). The combination of central hypothyroidism, hypogonadotropic hypogonadism (amenorrhea with low/normal FSH and LH), and mild hyperprolactinemia is the classic presentation of a compressive pituitary mass (e.g., non-functioning pituitary macroadenoma). The mass destroys normal anterior pituitary tissue (causing hypothyroidism and hypogonadism) and compresses the pituitary stalk, blocking the normal inhibitory flow of dopamine from the hypothalamus to the lactotrophs. This 'stalk effect' results in mild to moderate hyperprolactinemia (typically < 200 ng/mL). The most appropriate next step is an MRI of the brain to characterize the structural lesion.

Adım Adım Çözüm

1
Analyze the thyroid studies to determine the etiology of the patient's hypothyroid symptoms.
The patient has low free T4 and an inappropriately low TSH, diagnostic of central (secondary) hypothyroidism.
Differentiating primary from central hypothyroidism is critical; primary hypothyroidism presents with a high TSH, whereas central hypothyroidism presents with a low or inappropriately normal TSH.
2
Evaluate the cause of hyperprolactinemia in the context of central hypothyroidism.
Mild hyperprolactinemia (< 200 ng/mL) alongside central hypothyroidism indicates pituitary stalk compression (the 'stalk effect') rather than severe primary hypothyroidism.
Primary hypothyroidism causes high TRH (which stimulates prolactin), but this patient has low TSH/TRH. The combined deficits point to a pituitary mass compressing the stalk (decreasing dopamine delivery to lactotrophs) and destroying normal pituitary tissue.
3
Determine the most appropriate next step in management for a suspected pituitary mass causing panhypopituitarism.
Magnetic resonance imaging (MRI) of the brain is indicated to visualize the pituitary fossa and characterize the compressive lesion.
Structural lesions must be identified before initiating hormonal therapies, as treatments like levothyroxine can precipitate an adrenal crisis if concomitant central adrenal insufficiency is present.

Anahtar Kavram

Patients presenting with secondary amenorrhea, central hypothyroidism (low TSH, low free T4), and mild hyperprolactinemia should undergo MRI of the brain to evaluate for a pituitary mass causing the 'stalk effect' and panhypopituitarism.
Tahmini Süre:2m 0s
Soru 908Soru →

A 22-year-old woman presents to the emergency department with acute-onset, severe bilateral lower abdominal pain and a fever of 38.8°C (101.8°F). She is sexually active with a new partner and states her last menstrual period was 6 weeks ago. Her blood pressure is 110/70 mm Hg, and pulse is 108/min.

Arrange the following steps in the most appropriate chronological order for evaluating and managing this patient's condition, from first to last.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Obtain a urine beta-hCG test -> Perform a bimanual pelvic examination -> Perform a transvaginal pelvic ultrasound -> Admit the patient and initiate intravenous cefoxitin and doxycycline -> Transition to oral doxycycline and metronidazole after 48 hours of clinical improvement.
The management of a reproductive-aged female presenting with lower abdominal pain and amenorrhea must begin with a pregnancy test to rule out an ectopic pregnancy. Once ectopic pregnancy is excluded (or concurrent with this testing in triage), a bimanual pelvic examination is performed to identify signs of pelvic inflammatory disease (PID) such as cervical motion tenderness. Given this patient's severe presentation (high fever, severe pain), she requires a transvaginal ultrasound to rule out a tubo-ovarian abscess (TOA). Because she meets criteria for inpatient management (high fever, severe illness, potential TOA), she should be admitted for intravenous antibiotics (e.g., cefoxitin and doxycycline). Finally, after demonstrating 24 to 48 hours of sustained clinical improvement on parenteral therapy, she can be transitioned to an oral regimen to complete a 14-day total course.

Adım Adım Çözüm

1
Rule out ectopic pregnancy
Obtain a urine beta-hCG test
The patient is a reproductive-aged female with amenorrhea and lower abdominal pain; ectopic pregnancy must be excluded immediately.
2
Establish a clinical diagnosis
Perform a bimanual pelvic examination
To identify cervical motion tenderness, uterine tenderness, or adnexal tenderness characteristic of pelvic inflammatory disease.
3
Evaluate for complications
Perform a transvaginal pelvic ultrasound
High fever and severe pain suggest complicated PID; imaging is needed to assess for a tubo-ovarian abscess.
4
Initiate acute treatment
Admit the patient and initiate intravenous cefoxitin and doxycycline
Severe PID requires hospitalization and intravenous antibiotics to prevent long-term sequelae like infertility or sepsis.
5
Provide definitive follow-up care
Transition to oral doxycycline and metronidazole after 48 hours of clinical improvement
After stabilizing on IV therapy, step-down oral therapy is indicated to complete the 14-day treatment course.

Anahtar Kavram

The diagnostic and management sequence for severe pelvic inflammatory disease (PID) involves ruling out pregnancy, establishing clinical signs, evaluating for tubo-ovarian abscess, initiating inpatient parenteral antibiotics, and stepping down to oral therapy upon improvement.
Soru 909Soru →

A 76-year-old woman comes to the clinic reporting a 6-month history of a vaginal bulge and pelvic pressure. She notes significant difficulty with bowel movements, frequently needing to press on the skin between her vagina and rectum to completely empty her bowels. Today, she noticed a few spots of blood on her undergarments. Her medical history is significant for severe chronic obstructive pulmonary disease requiring continuous home oxygen therapy, and a myocardial infarction 3 months ago. Her current medications include aspirin, metoprolol, atorvastatin, and a tiotropium inhaler. On pelvic examination, there is a prominent bulge of the posterior vaginal wall that extends 3 cm beyond the hymenal ring with the Valsalva maneuver. The cervix is flush with the vaginal vault and has no active bleeding or lesions. There is a superficial 3-mm mucosal ulceration on the dependent portion of the prolapsed posterior vaginal wall that oozes a small amount of blood when touched. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Fitting for a vaginal pessary

Cevap

Fitting for a vaginal pessary
The most appropriate next step in management for this patient is fitting for a vaginal pessary. She presents with advanced, symptomatic pelvic organ prolapse (specifically, a rectocele), evidenced by the vaginal bulge and the need to manually splint to defecate. The spotting is clearly attributed to the mucosal friction ulcer on the prolapsed tissue. While definitive treatment for a rectocele is surgical repair (posterior colporrhaphy), this patient has a history of a myocardial infarction 3 months ago and severe COPD on continuous oxygen. Elective surgery is generally contraindicated within 6 months of an MI due to a high risk of reinfarction and mortality. Therefore, non-surgical management with a pessary is the safest and most effective intervention to provide anatomical support and relieve her symptoms.

Adım Adım Çözüm

1
Identify the primary diagnosis and source of symptoms.
The patient has a symptomatic posterior vaginal wall prolapse (rectocele) causing defecatory dysfunction, and a friction ulcer on the prolapse causing vaginal spotting.
The history of a vaginal bulge, the need to manually splint the perineum to defecate, and the physical exam finding of a posterior wall defect protruding beyond the hymen confirm the diagnosis.
2
Evaluate the patient's surgical candidacy.
The patient is at an extremely high risk for surgical morbidity and mortality.
Elective surgery is generally contraindicated within 6 months of a myocardial infarction, and her concurrent severe COPD on home oxygen further increases anesthetic risk.
3
Select the most appropriate management based on the patient's risk profile.
Fitting for a vaginal pessary is the safest and most effective choice.
A pessary provides conservative, non-surgical support for the pelvic organs, alleviating the prolapse and allowing the friction ulcer to heal without subjecting the patient to prohibitive surgical risks.

Anahtar Kavram

Management of symptomatic pelvic organ prolapse in poor surgical candidates
Soru 910Soru →

A 3434-year-old gravida 33, para 22 at 3737 weeks gestation is brought to the labor and delivery triage complaining of a sudden onset of intense, constant abdominal pain accompanied by a moderate amount of dark red vaginal bleeding. Her medical history is significant for chronic hypertension. Her vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 168/105 mmHg168/105\text{ mmHg}, heart rate of 112/min112/\text{min}, and respiratory rate of 18/min18/\text{min}. Physical examination reveals a uniformly rigid and exquisitely tender uterus. A bedside ultrasound confirms a live fetus in cephalic presentation but does not visualize a retroplacental hematoma. Laboratory studies display a hemoglobin level of 10.6 g/dL10.6\text{ g/dL} and a platelet count of 140,000/mm3140,000/\text{mm}^3. The continuous fetal monitor indicates a baseline heart rate of 105/min105/\text{min}, absent variability, and recurrent late decelerations. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Emergent surgical delivery of the fetus

Cevap

The most appropriate next step is emergent surgical delivery of the fetus.
The correct answer involves immediately proceeding to the operating room for an emergent surgical delivery. This patient's presentation of sudden, severe abdominal pain, dark vaginal bleeding, and a rigid, tender uterus is highly characteristic of placental abruption, an obstetric emergency involving premature separation of the placenta. The continuous fetal monitor shows a baseline bradycardia (105/min105/\text{min}), absent variability, and recurrent late decelerations, which define a Category III fetal heart rate tracing. This pattern indicates severe uteroplacental insufficiency, fetal hypoxia, and acidemia. When a Category III tracing occurs secondary to a placental abruption, and vaginal delivery is not imminent, the standard of care is an immediate emergent cesarean delivery to save the life of the fetus and control maternal hemorrhage.

Adım Adım Çözüm

1
Evaluate the maternal and fetal clinical presentation.
The patient exhibits signs of placental abruption (sudden severe abdominal pain, rigid uterus, dark vaginal bleeding) and the fetal monitor shows a Category III tracing (baseline 105/min105/\text{min}, absent variability, late decelerations).
Initial obstetric triage requires assessing both maternal hemodynamic stability and fetal well-being to determine the urgency of intervention.
2
Determine the necessary intervention based on the fetal heart rate tracing.
A Category III tracing indicates severe fetal acidemia and impending fetal demise, necessitating immediate resolution.
Category III tracings are abnormal and predictive of abnormal fetal acid-base status at the time of observation, requiring prompt intervention.
3
Select the optimal mode of delivery.
Emergent surgical delivery (cesarean section) is the most appropriate definitive management.
Since vaginal delivery is not imminent in a patient who just arrived at triage, an emergent laparotomy is required to quickly deliver the compromised fetus and control the abruption.

Anahtar Kavram

Severe placental abruption complicated by a Category III fetal heart rate tracing requires immediate emergent surgical delivery to prevent fetal demise.
Soru 911Soru →

During a routine health maintenance visit, a 61-year-old G2P2 complains of a three-month history of progressive abdominal bloating, early satiety, and pelvic heaviness. Her last menstrual period was 10 years ago, and she has never used hormone replacement therapy. Vital signs are within normal limits. Abdominal examination reveals fullness in the lower quadrants. Bimanual pelvic examination identifies a palpable, firm, irregular, and fixed mass in the right adnexa. Arrange the following steps in the most appropriate chronological sequence for the diagnostic workup and therapeutic management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with transvaginal ultrasonography to characterize the physical properties of the mass, followed by measurement of serum CA-125. These diagnostic data points are then used to calculate a malignancy risk index, which directs the referral of the patient to a gynecologic oncologist. The specialist ultimately performs an exploratory laparotomy for staging and cytoreduction.
The established standard of care for a postmenopausal woman presenting with a suspicious pelvic mass dictates a sequential, structured approach. The workup must begin with transvaginal ultrasonography to establish the presence and morphological complexity of the mass. Once a complex mass is confirmed, serum CA-125 is measured. Because isolated clinical intuition is insufficient, these factors are objectively combined into a risk stratification model (such as the Risk of Malignancy Index). Patients identified as high-risk must then be referred to a gynecologic oncologist. Finally, the subspecialist performs the definitive intervention: an exploratory laparotomy for histological confirmation, staging, and tumor cytoreduction.

Adım Adım Çözüm

1
Characterize the adnexal mass morphologically
Transvaginal ultrasound is performed
This is the gold-standard initial modality to assess the physical properties of any newly palpated pelvic mass and identify features suspicious for malignancy.
2
Assess biochemical tumor markers
Serum CA-125 is measured
Provides vital serologic evidence to support the suspicion of epithelial ovarian malignancy in a postmenopausal patient presenting with a complex adnexal mass.
3
Synthesize data for objective risk stratification
A malignancy risk index is calculated
Combines morphological (ultrasound), serological (CA-125), and clinical (menopausal status) data into a standardized triage score.
4
Determine the appropriate level of surgical care
Patient is referred to a gynecologic oncologist
High-risk predictive scores mandate specialized surgical expertise to ensure the patient receives appropriate staging and maximal debulking.
5
Perform definitive diagnostic and therapeutic management
Exploratory laparotomy is conducted
Achieves both definitive histological diagnosis and therapeutic cytoreduction, which directly correlates with improved survival outcomes.

Anahtar Kavram

Sequential triage, risk stratification, and surgical management of a suspicious adnexal mass in a postmenopausal patient.
Soru 912Soru →

A 74-year-old woman is brought to the clinic by her son for evaluation of urinary incontinence that has worsened over the past 6 months. The patient experiences sudden, overwhelming urges to urinate and frequently leaks large amounts of urine before she can reach the bathroom. These episodes occur during both the day and night. She has attempted pelvic floor muscle exercises and timed voiding for the last 3 months with minimal benefit. The patient denies dysuria, hematuria, or abdominal pain. Her medical history is significant for hypertension, hyperlipidemia, and mild Alzheimer dementia. Her current medications are amlodipine, atorvastatin, and donepezil. Vital signs are within normal limits. Pelvic examination demonstrates healthy, well-estrogenized vaginal mucosa without evidence of pelvic organ prolapse. A bladder scan shows a post-void residual volume of 30 mL. Urinalysis is negative for leukocyte esterase, nitrites, and blood. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Prescription of oral mirabegron

Cevap

The most appropriate next step in management is the prescription of oral mirabegron.
The correct approach for this patient with urgency urinary incontinence (UUI) who has failed behavioral therapy is to initiate a beta-3 adrenergic agonist. She presents with classic UUI symptoms: sudden, intense urges to void followed by large-volume leakage. While first-line medical therapy for UUI typically includes either antimuscarinics (e.g., oxybutynin, tolterodine) or beta-3 agonists (e.g., mirabegron), her medical history dictates the choice. She has Alzheimer dementia and is taking donepezil, an acetylcholinesterase inhibitor. Acetylcholinesterase inhibitors work by increasing the concentration of acetylcholine in the synaptic cleft to improve cognition. Antimuscarinic drugs block acetylcholine receptors and can cross the blood-brain barrier. In elderly patients, especially those with baseline dementia, antimuscarinics can cause severe cognitive impairment, confusion, and hallucinations. Furthermore, they directly antagonize the therapeutic effect of donepezil. Mirabegron relaxes the detrusor muscle by stimulating sympathetic beta-3 receptors, entirely avoiding anticholinergic adverse effects, making it the safest and most effective choice for this patient.

Adım Adım Çözüm

1
Diagnose the type of urinary incontinence based on the patient's clinical presentation.
The patient has urgency urinary incontinence (overactive bladder), characterized by sudden urges to urinate and large-volume leakage.
Accurate phenotypic diagnosis is required to select the correct treatment pathway.
2
Evaluate prior conservative management efforts.
The patient has already failed first-line behavioral modifications (pelvic floor exercises, timed voiding) over a 3-month period.
Pharmacotherapy is indicated when conservative measures are insufficient to control symptoms.
3
Analyze the patient's comorbidities and current medication list for potential drug interactions.
The patient has Alzheimer dementia and is taking donepezil, which is an acetylcholinesterase inhibitor.
Certain urgency incontinence medications have anticholinergic properties that are strictly contraindicated in dementia.
4
Select the optimal pharmacologic agent.
Mirabegron (a beta-3 agonist) is chosen over antimuscarinic agents (like oxybutynin).
Beta-3 agonists relax the detrusor muscle without causing systemic anticholinergic adverse effects that cross the blood-brain barrier and worsen cognition.

Anahtar Kavram

Pharmacotherapy for urgency urinary incontinence in patients with dementia should utilize beta-3 adrenergic agonists (e.g., mirabegron) to avoid the cognitive side effects and pharmacological antagonism associated with antimuscarinic agents.
Soru 913Soru →

A 6868-year-old nulliparous woman comes to the clinic for a 11-month history of intermittent vaginal spotting. She went through menopause at age 5252. Her medical history is significant for obesity (BMI 36 kg/m236 \text{ kg/m}^2), type 2 diabetes mellitus, and essential hypertension. She takes metformin and lisinopril. Vital signs are within normal limits. Pelvic examination reveals normal external genitalia and a small amount of dark blood at the cervical os. Bimanual examination is limited by body habitus. A transvaginal ultrasound demonstrates an endometrial stripe thickness of 14 mm14 \text{ mm} with a heterogeneous appearance. No adnexal masses are noted. An office endometrial biopsy is attempted, but the sampling catheter cannot be advanced past the internal cervical os due to severe cervical stenosis. The patient reports significant discomfort, and the procedure is aborted. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Hysteroscopy with dilation and curettage

Cevap

Hysteroscopy with dilation and curettage
The correct answer is hysteroscopy with dilation and curettage. This patient presents with postmenopausal bleeding and a thickened, heterogeneous endometrial stripe (14 mm14 \text{ mm}) on ultrasound, a presentation highly concerning for endometrial hyperplasia or carcinoma, particularly given her underlying risk factors of obesity, nulliparity, and diabetes. The standard initial step is an office-based endometrial biopsy. However, in cases of severe cervical stenosis where the biopsy catheter cannot pass, or if an office biopsy yields non-diagnostic tissue in a high-risk patient, adequate tissue sampling must still be obtained. Hysteroscopy with dilation and curettage (D&C) allows for direct visualization of the endometrial cavity, targeted sampling of suspicious areas, and mechanical dilation of the stenotic cervix under anesthesia. Obtaining a preoperative histologic diagnosis is mandatory to properly plan the appropriate surgical staging (e.g., deciding whether lymph node dissection or omentectomy is necessary).

Adım Adım Çözüm

1
Analyze the patient's presentation and ultrasound findings.
The patient has postmenopausal bleeding with a 14 mm14 \text{ mm} thickened, heterogeneous endometrium and multiple risk factors (obesity, nulliparity), indicating a high risk for endometrial cancer.
Establishing the severity of the clinical picture dictates the urgency and necessity of obtaining a tissue diagnosis.
2
Evaluate the outcome of the initial diagnostic procedure.
The standard first-line test, an office endometrial biopsy, failed due to severe cervical stenosis.
Identifying procedural failure is necessary to determine the appropriate fallback step in the diagnostic algorithm.
3
Determine the definitive next step for obtaining tissue following a failed office biopsy.
Select hysteroscopy with dilation and curettage to obtain the mandatory tissue sample under anesthesia.
Surgical planning for potential endometrial cancer requires preoperative histologic confirmation, which cannot be bypassed or substituted with imaging.

Anahtar Kavram

Fallback diagnostic management for postmenopausal bleeding when office endometrial sampling fails.
Tahmini Süre:1m 30s
Soru 914Soru →

Match each clinical presentation of a urogynecologic condition with the most appropriate therapeutic intervention, taking into account the patient's specific comorbidities.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 62-year-old woman with bothersome urgency urinary incontinence and a known history of narrow-angle glaucoma.
A 58-year-old woman with sudden, uncontrollable urges to void whose blood pressure is consistently 170/100170/100 mm Hg despite multi-drug therapy.
A 65-year-old postmenopausal woman with involuntary urine leakage exclusively during exercise, accompanied by severe vaginal dryness and dyspareunia.
A 71-year-old woman with long-standing diabetes mellitus presenting with continuous, small-volume urine dribbling and a post-void residual volume of 450450 mL.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches pair the patient with narrow-angle glaucoma to a beta-3 agonist, the patient with severe hypertension to a muscarinic antagonist, the patient with postmenopausal atrophy to topical vaginal estrogen, and the patient with diabetic neurogenic bladder to clean intermittent catheterization.
The correct matches require applying pharmacological knowledge and understanding specific contraindications. Narrow-angle glaucoma precludes anticholinergic use, making beta-3 agonists the drug of choice for overactive bladder. Conversely, uncontrolled hypertension precludes the use of beta-3 agonists, making anticholinergics safer. Hypoestrogenism contributing to stress incontinence and vaginal atrophy is best managed with topical estrogen. Finally, overflow incontinence from a neurogenic bladder (diabetic neuropathy) requires mechanical emptying via catheterization rather than pharmacotherapy.

Adım Adım Çözüm

1
Identify the underlying type of incontinence for each patient.
The patients suffer from urgency incontinence (patients 1 and 2), stress incontinence with atrophy (patient 3), and overflow incontinence (patient 4).
Establishing the mechanism of leakage determines the broad category of appropriate treatment.
2
Evaluate the medical history for absolute or relative contraindications to first-line pharmacotherapies.
Patient 1 cannot receive anticholinergics (glaucoma). Patient 2 cannot receive beta-3 agonists (uncontrolled hypertension).
Comorbidities heavily influence the choice of medical therapy in urogynecology to avoid severe adverse events.
3
Select the safest and most effective targeted intervention for each scenario.
Patient 1 receives mirabegron; Patient 2 receives oxybutynin; Patient 3 receives topical estrogen; Patient 4 receives catheterization.
This aligns the pathophysiology with safe pharmacological and non-pharmacological management principles.

Anahtar Kavram

Pharmacologic and non-pharmacologic management of urinary incontinence syndromes based on specific patient comorbidities.
Soru 915Soru →

A 34-year-old woman comes to the office to establish care. Her primary concern today is an intense, burning vaginal itch accompanied by a thick, white discharge that began five days ago. She is particularly distressed because this marks her fourth identical presentation in the past ten months. She notes that during each of the three prior occurrences, a clinician at a local urgent care prescribed a single antifungal tablet that provided complete relief within days, only for the symptoms to return a few months later. Her medical history is significant for type 2 diabetes mellitus, and her most recent hemoglobin A1c was 8.4%. On pelvic examination, there is marked erythema and edema of the vulva and vagina, with adherent, curd-like discharge in the vaginal vault. The vaginal pH is 4.2. A wet mount preparation with 10% potassium hydroxide reveals abundant budding yeast and pseudohyphae. Which of the following is the most appropriate pharmacologic management strategy for this patient?

Cevabı ve açıklamayı göster

Cevap: Oral fluconazole every 72 hours for three doses, followed by weekly oral fluconazole for 6 months

Cevap

Oral fluconazole every 72 hours for three doses, followed by weekly oral fluconazole for 6 months
This patient presents with classical signs and symptoms of vulvovaginal candidiasis (VVC), including intense pruritus, curd-like discharge, normal vaginal pH (4.2), and pseudohyphae on wet mount. Crucially, she reports this is her fourth episode within the past 10 months. Recurrent vulvovaginal candidiasis (RVVC) is strictly defined as four or more symptomatic episodes in a 12-month period. Patients with poorly controlled diabetes mellitus are at an increased risk for RVVC due to hyperglycemia enhancing yeast colonization and adhesion. The standard of care for RVVC involves a mandatory two-phase treatment approach: an induction phase to achieve clinical remission (typically oral fluconazole 150 mg every 72 hours for 3 doses) followed by a suppressive maintenance phase (weekly oral fluconazole for 6 months). Without this prolonged maintenance phase, symptomatic relapse is highly likely in these patients, as evidenced by her history of recurring after single-dose treatments.

Adım Adım Çözüm

1
Identify the primary diagnosis based on clinical presentation and microscopic findings.
Vulvovaginal candidiasis (VVC) confirmed by thick white discharge, severe pruritus, pH of 4.2, and pseudohyphae on the potassium hydroxide preparation.
To establish the baseline infection type before determining severity or chronicity.
2
Classify the VVC episode based on frequency and patient risk factors.
The patient has recurrent VVC (RVVC), defined as 4 or more symptomatic episodes in a 12-month period, likely exacerbated by her poorly controlled type 2 diabetes mellitus.
Management guidelines differ significantly between uncomplicated, severe, and recurrent VVC.
3
Determine the guideline-concordant treatment for RVVC.
Induction therapy with 3 doses of oral fluconazole every 72 hours, followed by a 6-month maintenance regimen of weekly oral fluconazole.
Short-course therapy is insufficient for RVVC; prolonged maintenance is required to suppress the infection and prevent rapid relapse.

Anahtar Kavram

Diagnosis and guideline-concordant treatment of recurrent vulvovaginal candidiasis (RVVC) using an induction and 6-month maintenance antifungal phase.
Soru 916Soru →

Match each patient's clinical and urodynamic presentation with the most accurate underlying pathophysiologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 65-year-old woman with continuous dribbling and a postvoid residual of 500 mL; cystometry shows absent pressure rise during attempted voiding.
A 45-year-old woman with leakage during coughing; urethral pressure profilometry shows maximal urethral closure pressure of 15 cm H2O and a Q-tip test angle of 15 degrees.
A 55-year-old woman with frequent, large-volume leakage preceded by a sudden urge; urodynamics demonstrate uninhibited pressure spikes during bladder filling.
A 42-year-old woman with continuous, painless leakage two weeks after an abdominal hysterectomy; dye instilled into the bladder appears in the vaginal vault.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations match exactly to their distinct underlying mechanisms: the patient with absent voiding contractions matches Detrusor underactivity; the patient with low urethral closure pressure and low Q-tip angle matches Intrinsic sphincter deficiency; the patient with uninhibited filling contractions matches Detrusor overactivity; and the patient with a positive dye test after surgery matches Vesicovaginal fistula.
Each clinical presentation aligns precisely with a specific pathophysiologic mechanism. Detrusor underactivity causes an acontractile bladder resulting in overflow incontinence. Intrinsic sphincter deficiency presents with stress leakage due to an open, weak urethra without hypermobility. Detrusor overactivity features spontaneous bladder contractions leading to urgency incontinence. A vesicovaginal fistula presents as continuous bypass leakage following pelvic surgery.

Adım Adım Çözüm

1
Analyze the clinical presentation and urodynamic findings for each patient.
Identified the primary symptom pattern (e.g., stress leakage, urgency, continuous leakage, overflow) and objective data (postvoid residual, cystometry findings).
Clinical symptoms provide the presumptive diagnosis, while urodynamics confirm the exact pathophysiologic mechanism.
2
Evaluate the patient with continuous dribbling, high postvoid residual volume, and absent detrusor contraction.
Matched to Detrusor underactivity.
An acontractile bladder fails to empty properly, causing urine retention and subsequent overflow incontinence.
3
Evaluate the patient with stress leakage, a Q-tip angle < 30 degrees, and low urethral closure pressure.
Matched to Intrinsic sphincter deficiency.
Lack of urethral hypermobility combined with a weak sphincter indicates intrinsic sphincter deficiency rather than typical urethral hypermobility.
4
Evaluate the patient with urgency and uninhibited filling pressure spikes.
Matched to Detrusor overactivity.
Spontaneous detrusor contractions during the filling phase are the classic urodynamic hallmark of urgency incontinence.
5
Evaluate the patient with continuous post-surgical leakage and a positive dye test.
Matched to Vesicovaginal fistula.
The passage of instilled dye from the bladder into the vagina confirms an anatomical communication.

Anahtar Kavram

Pathophysiology and Urodynamic Evaluation of Urinary Incontinence
Soru 917Soru →

A multiparous 62-year-old patient comes to the physician seeking treatment for involuntary urinary leakage that has progressively worsened over the past year. She describes two distinct patterns: losing small amounts of urine during physical exertion (such as lifting groceries) and experiencing a sudden, overwhelming need to void that sometimes results in larger volume leakage before she can reach the toilet. She takes no daily medications. Pelvic examination reveals normal vaginal estrogenization and a positive cough stress test. Assuming the patient's symptoms persist and fail to improve adequately at each successive stage of treatment, arrange the following clinical interventions in the correct sequential order from initial presentation to definitive management.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with urinalysis to rule out infection, followed by conservative behavioral therapies. If those fail, pharmacological management for urgency is initiated. If symptoms remain refractory and surgery is considered, urodynamic testing is performed first, followed ultimately by surgical intervention (mid-urethral sling).
The management of mixed urinary incontinence follows a stepwise escalation based on invasiveness and risk. Urinalysis is the mandatory first step to exclude reversible causes. Once excluded, first-line therapy is always conservative (pelvic floor muscle training and behavioral modification). If symptoms persist, second-line therapy typically targets the most bothersome symptom; for the urgency component, medical therapy (antimuscarinics/beta-3 agonists) is utilized. If symptoms are refractory to these steps and surgery is contemplated for the stress component, urodynamic testing must first be performed to carefully evaluate bladder function and rule out voiding dysfunction. Finally, surgery (such as a mid-urethral sling) is performed as the definitive management.

Adım Adım Çözüm

1
Obtain a urinalysis and urine culture.
Rules out transient, reversible causes of incontinence.
A urinary tract infection can cause acute urgency and incontinence; it must be excluded before establishing a chronic diagnosis.
2
Initiate behavioral modifications, a voiding diary, and pelvic floor muscle training.
Improves pelvic floor strength and optimizes fluid intake.
Conservative management is the lowest-risk, first-line therapy for both stress and urgency urinary incontinence.
3
Prescribe a trial of a pharmacological agent, such as a beta-3 adrenergic agonist or an antimuscarinic.
Pharmacologically suppresses detrusor overactivity.
If conservative measures fail, second-line therapy targets the urgency component of mixed incontinence.
4
Perform complex multichannel urodynamic testing to formally evaluate bladder physiology.
Objectively measures bladder compliance, capacity, and detrusor function.
Required in cases of mixed urinary incontinence when initial therapies fail and surgical intervention is being considered, ensuring no underlying voiding dysfunction.
5
Proceed with a surgical intervention such as a mid-urethral sling placement.
Provides anatomical support to the urethra.
Reserved as a last resort for the stress component of incontinence after conservative measures are exhausted and urodynamics confirm the indication.

Anahtar Kavram

Stepwise evaluation and management of Mixed Urinary Incontinence
Soru 918Soru →

An evaluation is requested for a 36-year-old female patient presenting with ongoing urinary difficulties. For the past four months, she has experienced sharp pain during micturition, significant discomfort during sexual intercourse, and involuntary fluid leakage. She specifically notes that small amounts of urine continuously dribble from her vagina immediately after she stands up from the toilet. Despite completing two separate courses of empirical oral antibiotics for presumed cystitis over the last half-year, her symptoms have not resolved. A urine culture obtained one week ago demonstrates no bacterial growth. Vital signs are within normal limits. On pelvic examination, the provider palpates a 3-cm, tender, fluctuant mass situated on the anterior vaginal wall. When gentle upward pressure is applied to this structure, a small volume of purulent fluid is expressed from the urethral meatus. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Magnetic resonance imaging of the pelvis

Cevap

Magnetic resonance imaging of the pelvis is the most appropriate next step to confirm the diagnosis of a urethral diverticulum.
The correct answer is magnetic resonance imaging of the pelvis. This patient's presentation is classic for a urethral diverticulum, a localized outpouching of the urethral mucosa into the surrounding tissue. Patients typically present with the '3 Ds': dysuria, dyspareunia, and postvoid dribbling. On physical examination, a tender mass is often palpable on the anterior vaginal wall, and compressing it may produce purulent or bloody discharge from the urethral meatus. Because surgical excision is the definitive treatment, precise anatomical mapping is required. Magnetic resonance imaging (MRI) of the pelvis is the diagnostic test of choice due to its superior soft-tissue resolution, which helps define the diverticulum's size, exact location, and potential communication with the urethral lumen.

Adım Adım Çözüm

1
Analyze the patient's symptom profile.
The patient reports dysuria, dyspareunia, and postvoid dribbling.
These three symptoms constitute the classic '3 Ds' triad that is highly indicative of a urethral diverticulum.
2
Correlate the clinical history with the physical examination findings.
Palpation reveals a tender anterior vaginal wall mass that expresses purulent fluid from the urethra upon compression.
This physical finding confirms that the mass is an infected outpouching connected to the urethral lumen.
3
Select the most accurate diagnostic modality to guide definitive treatment.
Magnetic resonance imaging (MRI) of the pelvis is chosen.
MRI provides the highest spatial resolution to precisely define the size, exact location, and complexity of the diverticulum prior to surgical excision.

Anahtar Kavram

Diagnosis of Urethral Diverticulum
Soru 919Soru →

During an initial reproductive endocrinology consultation, a 27-year-old woman seeks evaluation for an inability to conceive over the past 16 months. She previously experienced regular 28-day menstrual cycles, but they became progressively infrequent and completely ceased 8 months ago. Detailed history reveals that over the past year, the patient transitioned to a strict ketogenic diet and began high-intensity training for an ultramarathon, resulting in an intentional 9-kg weight loss. She notes a recent increase in mild facial acne. Her current body mass index is 19.8 kg/m219.8 \text{ kg/m}^2. Vital signs are within normal limits. Pelvic ultrasonography reveals a normal-appearing uterus and bilaterally enlarged ovaries, each containing 15 to 20 small, subcapsular follicles measuring 4 to 8 mm.

Laboratory studies show the following:
Follicle-stimulating hormone: 1.8 mIU/mL
Luteinizing hormone: 1.1 mIU/mL
Estradiol: 15 pg/mL
Prolactin: 9 ng/mL
Thyroid-stimulating hormone: 1.6 mU/L
Total testosterone: 25 ng/dL

Her partner's semen analysis is within normal limits. The patient strongly desires immediate pregnancy and strictly declines any modifications to her current diet or exercise regimen. Which of the following is the most appropriate pharmacologic intervention to induce ovulation in this patient?

Cevabı ve açıklamayı göster

Cevap: Administration of exogenous gonadotropins

Cevap

Administration of exogenous gonadotropins
This patient's presentation of secondary amenorrhea following intense exercise and weight loss, combined with low FSH, low LH, and low estradiol, is diagnostic of Functional Hypothalamic Amenorrhea (FHA). Her energy deficit has led to a suppression of hypothalamic GnRH pulsatility. While she exhibits mild acne and polycystic ovarian morphology (PCOM) on ultrasound—which can act as clinical red herrings for Polycystic Ovary Syndrome (PCOS)—her strictly normal testosterone and low gonadotropins firmly rule out PCOS. PCOM is a frequent incidental finding in FHA due to the lack of LH surges causing arrested follicular growth.

Because the patient declines lifestyle modifications (which is normally the first-line treatment for FHA), pharmacologic ovulation induction is necessary to treat her infertility. In a hypogonadotropic, hypoestrogenic state, the hypothalamus is fundamentally inactive. Therefore, medications that work by blocking estrogen negative feedback at the hypothalamus to increase endogenous GnRH (such as the aromatase inhibitor letrozole or the selective estrogen receptor modulator clomiphene) are completely ineffective. To achieve ovulation, the central defect must be bypassed by directly stimulating the ovaries with exogenous gonadotropins (FSH and LH) or by administering pulsatile GnRH.

Adım Adım Çözüm

1
Analyze the patient's history and vital signs.
The patient has secondary amenorrhea and infertility following significant weight loss and intense endurance training, despite maintaining a normal BMI.
Intense exercise and caloric deficit are classic triggers for central suppression of the reproductive axis.
2
Interpret the laboratory and imaging findings.
Labs show hypogonadotropic hypogonadism (low FSH, LH, and estradiol) with normal prolactin, TSH, and testosterone. Ultrasound shows polycystic ovarian morphology (PCOM).
Accurate interpretation distinguishes Functional Hypothalamic Amenorrhea (FHA) from PCOS. PCOM is frequently seen in FHA due to arrested follicular development; however, the lack of hyperandrogenemia and the low gonadotropins rule out PCOS.
3
Determine the pathophysiological requirement for ovulation induction.
The pharmacological intervention must bypass the suppressed hypothalamus.
Because the hypothalamus is functionally suppressed by the energy deficit, drugs that rely on modifying central feedback mechanisms (like aromatase inhibitors or SERMs) will be ineffective.
4
Select the appropriate targeted therapy.
Administration of exogenous gonadotropins is chosen.
Since the patient refuses lifestyle modifications (the best initial step), direct stimulation of the ovaries with exogenous FSH/LH is required to achieve follicular development and ovulation.

Anahtar Kavram

Ovulation induction in Functional Hypothalamic Amenorrhea (hypogonadotropic hypogonadism) requires direct ovarian stimulation using exogenous gonadotropins or pulsatile GnRH, as the suppressed hypothalamus cannot respond to antiestrogen medications like letrozole or clomiphene.
Soru 920Soru →

Match each gynecologic procedure or intraoperative surgical step to its most classically associated complication or risk.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Operative hysteroscopy using glycine or sorbitol distending media
Aggressive sharp uterine curettage following a missed abortion
Cold knife conization of the cervix for high-grade dysplasia
Ligation of the uterine vessels within the cardinal ligaments during hysterectomy

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Operative hysteroscopy with glycine media matches with hyponatremia and volume overload. Aggressive sharp curettage matches with intrauterine synechiae. Cold knife conization matches with cervical insufficiency. Ligation of the uterine vessels matches with ureteral obstruction or transection.
Each procedure carries a unique, highly tested complication based on either anatomical proximity (the ureter and the uterine artery) or the mechanism of the procedure (hypotonic fluid absorption, endometrial basalis destruction, or cervical stroma removal).

Adım Adım Çözüm

1
Analyze operative hysteroscopy with hypotonic media.
Matches with hyponatremia and volume overload.
Systemic intravascular absorption of hypotonic distending media causes a dilutional drop in serum sodium.
2
Evaluate aggressive sharp curettage.
Matches with intrauterine synechiae (Asherman syndrome).
Damage to the regenerative basalis layer of the endometrium causes intrauterine scar tissue formation.
3
Assess cold knife conization.
Matches with cervical insufficiency in subsequent pregnancies.
Removal of structural cervical stroma permanently weakens the cervix, predisposing to future preterm birth or miscarriage.
4
Review ligation of uterine vessels.
Matches with ureteral obstruction or transection.
The ureter runs immediately posterior and inferior to the uterine artery, risking clamping or ligation if surgical margins are too wide.

Anahtar Kavram

Understanding the precise anatomical and physiological mechanisms behind specific gynecologic surgical complications is essential for anticipation and prevention.
ÖncekiSayfa 46 / 53Sonraki
Obstetrics and Gynecology Alıştırma Soruları — USMLE Step 2 CK — Sayfa 46 | Examkin